Clinical Study

Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study

Figure 1

Treatment algorithm for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). PIPAC treatment was scheduled as repeated application (3x) at 6-week intervals. Thoracoabdominal computed tomography (CT) was performed 4 weeks prior to PIPAC#1, between PIPAC#2 and PIPAC#3, and after the completion of intraperitoneal treatment to search for extraperitoneal disease. Quality of Life (QoL) was systematically assessed (EORTC QLQ-C30) during every patient encounter: in outpatient consultation, before surgery, and at discharge.